Blog Post Title
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Menu
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Since the outbreak of COVID-19, researchers have observed a myriad of symptoms and complications associated with the infection. Among these, dysautonomia, a disorder of the ANS, has emerged as a notable concern (1). The ANS regulates involuntary bodily functions, including heart rate, blood pressure, and digestion. Dysautonomia encompasses a range of symptoms such as tachycardia, orthostatic intolerance, and gastrointestinal disturbances.
In a groundbreaking revelation, recent scientific studies have started to uncover a potential link between the Epstein-Barr Virus (EBV) — best known for causing mononucleosis or “mono” — and various forms of dysautonomia, including Postural Orthostatic Tachycardia Syndrome (POTS), as well as other nerve damage conditions. This connection, while still under investigation, offers new insights into the complexities of neuroimmune interactions and their impact on human health.
Patients often experience dizziness, fatigue, and palpitations (1). ADHD, on the other hand, is a neurodevelopmental disorder marked by symptoms of inattention, hyperactivity, and impulsivity (2).
Many individuals who have recovered from COVID-19 continue to experience persistent symptoms such as fatigue, cognitive issues, and gastrointestinal problems.
There are several types of postural orthostatic tachycardia syndrome (POTS). It is critical to understand the distinction between these because
A study found the biggest cohort of postural orthostatic tachycardia syndrome (POTS) patients up to now, together with the researchers
“I think that we have identified a biomarker. We now might have the ability to diagnosis this, or at least